newsfilter
← Latest News
Business Wire·

Icosavax Announces Pricing of Upsized Initial Public Offering

Icosavax, Inc. (NASDAQ:ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases, today anno